In people with amyotrophic lateral
sclerosis, overall quality of life was related to psychological, social and
spiritual factors but not physical status.
Clinical Problem: A 62
year old woman with a recent diagnosis of amyotrophic lateral sclerosis wishes
to discuss how the disease will impact her quality of life.
Clinical Question: What are the determinants of quality of life (QOL) in patients with amyotrophic lateral sclerosis (ALS)?
Search Strategy: PubMed, SUMsearch and the Cochrane Reviews database were searched using the MeSH terms “amyotrophic lateral sclerosis” AND “quality of life” without search limits. The Pubmed search yielded 224 articles and the SUMsearch and Cochrane search yielded 74 articles together. No Cochrane reviews directly assessed QOL in ALS. The SUMsearch results were eliminated because as they did not involve quality of life assessment, were clinical guidelines or were already included in the Pubmed results. Of the 224 articles found using PubMed, 159 were not relevant to the clinical question, 22 were excluded because the study was establishing the validity and reliability of a quality of life assessment tool and the remaining studies were eliminated as they were assessing the effect of a specific intervention on quality of life in ALS rather than global influences on quality of life. There were 2 remaining articles. The final article was chosen based on the fact that it investigated broad determinants of QOL in ALS at a single point in time.
Clinical Bottom Lines:
The Evidence: The study in question investigated quality of life in 80 consecutive patients from a specialized health care centre in Italy with definite, probable or laboratory supported probable ALS (El Escorial criteria) using two different tools: the Schedule for the Evaluation of QoL-Direct Weighting (SEIQoL-DW) and the McGill QoL questionnaire (MQOL). The QOL data from the questionnaires was then compared to patient demographics, clinical status, mental status, depression and hopelessness, social support, social attitudes, religiosity and social status using previously established assessment tools for each domain. A stepwise linear regression model was used with a Bonferroni comparison for multiple statistical comparisons. The patients included in this study had a mean age of 59.8 years and a mean duration of disease at the time of interview of 2.1 years.
Data:
Predictor variables – Amongst the predictor scales assessed 20 patients had a ZDS indicating overt depression, 7 patients had a BHS indicating severe hopelessness and 13 had a BHS indicating moderate hopelessness. A total of 19 patients were taking selective serotonin reuptake inhibitors.
Explanatory variables – Table 1. Predictor variables having maximal influence on the QOL assessment tools being studied.
|
QOL
instrument |
Predictor
Variables |
Domain
of QOL |
%
Variance |
|
Schedule for the Evaluation of QoL-Direct Weighting |
SSQ-S p=0.0021 ZDS p=0.03 IIR-Pr p=0.04 PSQ p=0.05 |
-social support -depression -religiosity -social status |
44% |
|
McGill QoL
questionnaire - total |
SSQ-S p=0.003 PSQ p=0.012 ALS-FRS p=0.04 |
-social support -social status -clinical status |
47% |
|
MQOL-physical well being |
ZDS p=0.0001 ALS-FRS p=0.02 |
-depression -clinical status |
|
|
MQOL-physical symptoms |
ALS-Ph p=0.01 |
-clinical status |
|
|
MQOL-existential well being |
SSQ-S p=0.01 ZDS p=0.006 |
-social support -depression |
|
|
MQOL-psychological symptoms |
ZDS p=0.0001 SWS-F p=0.0002 SSQ-S p=0.004 |
-depression -social attitudes -social support |
|
|
MQOL-support |
SSQ-S p=0.003 BHS p=0.02 |
-social support -hopelessness |
|
|
MQOL-Single Item Score |
SSQ-S p=0.009 ZDS p=0.015 SWS-F p=0.02 PSQ p=0.04 |
-social support -depression -social attitudes -social status |
52% |
Abbreviations:
ALS-FRS=ALS Functional Rating Scale, IIR-Pr=Idler Index of Religiosity Private
Score, ZDS=Zung Depression Score, BHS=Beck
Hopelessness Scale, SSQ-S=Social Support Questionnaire Satisfaction,
SWS-F=Social Withdrawal Scale Family, PSQ=Psychosocial Questionnaire.
Comments:
Key words: amyotrophic lateral sclerosis, quality of life, psychological well being
Appraiser: Dr. Teneille Gofton and the UWO Evidence Based Neurology Group.
Date appraised: September 4, 2007
Copyright Ó2002-2007
Evidence Based
Neurology Group
University of Western Ontario